MYELOABLATIVE THERAPY WITH STEM-CELL SUPPORT (BMT) IS FEASIBLE AND EFFECTIVE IN MANTLE CELL LYMPHOMA (MCL) - A SINGLE-CENTER EXPERIENCE OVER 5 YEARS

Authors
MILPIED N GAILLARD F MOREAU P SOUCHET J MAHE B RAPP MJ BULABOIS CE MORINEAU N HAROUSSEAU JL
Citation
N. Milpied et al., MYELOABLATIVE THERAPY WITH STEM-CELL SUPPORT (BMT) IS FEASIBLE AND EFFECTIVE IN MANTLE CELL LYMPHOMA (MCL) - A SINGLE-CENTER EXPERIENCE OVER 5 YEARS, Experimental hematology, 25(8), 1997, pp. 18-18
Citations number
NO
Categorie Soggetti
Medicine, Research & Experimental",Hematology
Journal title
Experimental hematology → ACNP
ISSN journal
0301472X
Volume
25
Issue
8
Year of publication
1997
Pages
18 - 18
Database
ISI
SICI code
0301-472X(1997)25:8<18:MTWSS(>2.0.ZU;2-T